SomaLogic, Inc. (SLGCW) Stock Competitors & Peer Comparison
See (SLGCW) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SLGCW | $0.09 | -28.33% | 396.2M | -0.16 | -$0.53 | N/A |
| VEEV | $192.74 | +4.62% | 31.3B | 23.14 | $8.33 | N/A |
| GEHC | $65.57 | +1.09% | 29.8B | 14.38 | $4.56 | +0.21% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSGU | $224.20 | -2.43% | 13.7B | 206.63 | $1.11 | N/A |
| BTSG | $69.03 | -1.17% | 13.5B | 55.67 | $1.24 | N/A |
| TEM | $60.27 | -2.16% | 10.5B | -120.54 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $95.31 | +3.27% | 8B | 22.27 | $4.28 | N/A |
| HNGE | $84.05 | +1.27% | 6.6B | 43.66 | $1.95 | N/A |
Stock Comparison
SLGCW vs VEEV Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, VEEV has a market cap of 31.3B. Regarding current trading prices, SLGCW is priced at $0.09, while VEEV trades at $192.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas VEEV's P/E ratio is 23.14. In terms of profitability, SLGCW's ROE is -0.19%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, SLGCW is more volatile compared to VEEV. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check VEEV's competition here
SLGCW vs GEHC Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, GEHC has a market cap of 29.8B. Regarding current trading prices, SLGCW is priced at $0.09, while GEHC trades at $65.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas GEHC's P/E ratio is 14.38. In terms of profitability, SLGCW's ROE is -0.19%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, SLGCW is more volatile compared to GEHC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check GEHC's competition here
SLGCW vs GEHCV Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, SLGCW is priced at $0.09, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas GEHCV's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, SLGCW is more volatile compared to GEHCV. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check GEHCV's competition here
SLGCW vs BTSGU Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, BTSGU has a market cap of 13.7B. Regarding current trading prices, SLGCW is priced at $0.09, while BTSGU trades at $224.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas BTSGU's P/E ratio is 206.63. In terms of profitability, SLGCW's ROE is -0.19%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, SLGCW is more volatile compared to BTSGU. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check BTSGU's competition here
SLGCW vs BTSG Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, BTSG has a market cap of 13.5B. Regarding current trading prices, SLGCW is priced at $0.09, while BTSG trades at $69.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas BTSG's P/E ratio is 55.67. In terms of profitability, SLGCW's ROE is -0.19%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, SLGCW is more volatile compared to BTSG. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check BTSG's competition here
SLGCW vs TEM Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, TEM has a market cap of 10.5B. Regarding current trading prices, SLGCW is priced at $0.09, while TEM trades at $60.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas TEM's P/E ratio is -120.54. In terms of profitability, SLGCW's ROE is -0.19%, compared to TEM's ROE of -0.70%. Regarding short-term risk, SLGCW is more volatile compared to TEM. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check TEM's competition here
SLGCW vs SGFY Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, SLGCW is priced at $0.09, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SGFY's P/E ratio is 70.91. In terms of profitability, SLGCW's ROE is -0.19%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, SLGCW is more volatile compared to SGFY. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SGFY's competition here
SLGCW vs HQY Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, HQY has a market cap of 8B. Regarding current trading prices, SLGCW is priced at $0.09, while HQY trades at $95.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas HQY's P/E ratio is 22.27. In terms of profitability, SLGCW's ROE is -0.19%, compared to HQY's ROE of +0.11%. Regarding short-term risk, SLGCW is more volatile compared to HQY. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check HQY's competition here
SLGCW vs HNGE Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, HNGE has a market cap of 6.6B. Regarding current trading prices, SLGCW is priced at $0.09, while HNGE trades at $84.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas HNGE's P/E ratio is 43.66. In terms of profitability, SLGCW's ROE is -0.19%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, SLGCW is more volatile compared to HNGE. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check HNGE's competition here
SLGCW vs RCM Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, SLGCW is priced at $0.09, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas RCM's P/E ratio is -102.21. In terms of profitability, SLGCW's ROE is -0.19%, compared to RCM's ROE of +0.00%. Regarding short-term risk, SLGCW is more volatile compared to RCM. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check RCM's competition here
SLGCW vs TXG Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, TXG has a market cap of 5B. Regarding current trading prices, SLGCW is priced at $0.09, while TXG trades at $39.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas TXG's P/E ratio is -229.47. In terms of profitability, SLGCW's ROE is -0.19%, compared to TXG's ROE of -0.03%. Regarding short-term risk, SLGCW is more volatile compared to TXG. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check TXG's competition here
SLGCW vs DOCS Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, DOCS has a market cap of 4.1B. Regarding current trading prices, SLGCW is priced at $0.09, while DOCS trades at $21.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas DOCS's P/E ratio is 14.28. In terms of profitability, SLGCW's ROE is -0.19%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, SLGCW is more volatile compared to DOCS. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check DOCS's competition here
SLGCW vs PRVA Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, SLGCW is priced at $0.09, while PRVA trades at $27.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas PRVA's P/E ratio is 171.00. In terms of profitability, SLGCW's ROE is -0.19%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, SLGCW is more volatile compared to PRVA. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check PRVA's competition here
SLGCW vs ONEM Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, SLGCW is priced at $0.09, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas ONEM's P/E ratio is -7.77. In terms of profitability, SLGCW's ROE is -0.19%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, SLGCW is more volatile compared to ONEM. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check ONEM's competition here
SLGCW vs HTFL Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, HTFL has a market cap of 2.4B. Regarding current trading prices, SLGCW is priced at $0.09, while HTFL trades at $27.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas HTFL's P/E ratio is -13.91. In terms of profitability, SLGCW's ROE is -0.19%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, SLGCW is more volatile compared to HTFL. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check HTFL's competition here
SLGCW vs PGNY Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, PGNY has a market cap of 2.4B. Regarding current trading prices, SLGCW is priced at $0.09, while PGNY trades at $30.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas PGNY's P/E ratio is 22.06. In terms of profitability, SLGCW's ROE is -0.19%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, SLGCW is more volatile compared to PGNY. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check PGNY's competition here
SLGCW vs PINC Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, PINC has a market cap of 2.3B. Regarding current trading prices, SLGCW is priced at $0.09, while PINC trades at $28.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas PINC's P/E ratio is 19.22. In terms of profitability, SLGCW's ROE is -0.19%, compared to PINC's ROE of -0.02%. Regarding short-term risk, SLGCW is more volatile compared to PINC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check PINC's competition here
SLGCW vs WGS Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, WGS has a market cap of 2B. Regarding current trading prices, SLGCW is priced at $0.09, while WGS trades at $67.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas WGS's P/E ratio is 79.42. In terms of profitability, SLGCW's ROE is -0.19%, compared to WGS's ROE of -0.28%. Regarding short-term risk, SLGCW is more volatile compared to WGS. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check WGS's competition here
SLGCW vs WGSWW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, WGSWW has a market cap of 1.8B. Regarding current trading prices, SLGCW is priced at $0.09, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas WGSWW's P/E ratio is -0.09. In terms of profitability, SLGCW's ROE is -0.19%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, SLGCW is less volatile compared to WGSWW. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check WGSWW's competition here
SLGCW vs TDOC Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, SLGCW is priced at $0.09, while TDOC trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas TDOC's P/E ratio is -10.22. In terms of profitability, SLGCW's ROE is -0.19%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, SLGCW is more volatile compared to TDOC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check TDOC's competition here
SLGCW vs NXGN Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, SLGCW is priced at $0.09, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas NXGN's P/E ratio is -266.00. In terms of profitability, SLGCW's ROE is -0.19%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, SLGCW is more volatile compared to NXGN. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check NXGN's competition here
SLGCW vs AGTI Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, SLGCW is priced at $0.09, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas AGTI's P/E ratio is -71.79. In terms of profitability, SLGCW's ROE is -0.19%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, SLGCW is more volatile compared to AGTI. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check AGTI's competition here
SLGCW vs OMDA Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, OMDA has a market cap of 1.3B. Regarding current trading prices, SLGCW is priced at $0.09, while OMDA trades at $22.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas OMDA's P/E ratio is 319.86. In terms of profitability, SLGCW's ROE is -0.19%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, SLGCW is more volatile compared to OMDA. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check OMDA's competition here
SLGCW vs NUTX Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, NUTX has a market cap of 1.2B. Regarding current trading prices, SLGCW is priced at $0.09, while NUTX trades at $196.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas NUTX's P/E ratio is 15.19. In terms of profitability, SLGCW's ROE is -0.19%, compared to NUTX's ROE of +0.31%. Regarding short-term risk, SLGCW is more volatile compared to NUTX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check NUTX's competition here
SLGCW vs CERT Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, SLGCW is priced at $0.09, while CERT trades at $6.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas CERT's P/E ratio is 17.87. In terms of profitability, SLGCW's ROE is -0.19%, compared to CERT's ROE of -0.01%. Regarding short-term risk, SLGCW is more volatile compared to CERT. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check CERT's competition here
SLGCW vs GDRX Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, SLGCW is priced at $0.09, while GDRX trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas GDRX's P/E ratio is 9.24. In terms of profitability, SLGCW's ROE is -0.19%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, SLGCW is more volatile compared to GDRX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check GDRX's competition here
SLGCW vs CCLDO Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, SLGCW is priced at $0.09, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas CCLDO's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, SLGCW is more volatile compared to CCLDO. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check CCLDO's competition here
SLGCW vs HSTM Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, HSTM has a market cap of 830M. Regarding current trading prices, SLGCW is priced at $0.09, while HSTM trades at $28.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas HSTM's P/E ratio is 37.38. In terms of profitability, SLGCW's ROE is -0.19%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, SLGCW is more volatile compared to HSTM. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check HSTM's competition here
SLGCW vs PHR Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, PHR has a market cap of 677.8M. Regarding current trading prices, SLGCW is priced at $0.09, while PHR trades at $10.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas PHR's P/E ratio is 39.16. In terms of profitability, SLGCW's ROE is -0.19%, compared to PHR's ROE of +0.03%. Regarding short-term risk, SLGCW is more volatile compared to PHR. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check PHR's competition here
SLGCW vs EVH Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, EVH has a market cap of 641.7M. Regarding current trading prices, SLGCW is priced at $0.09, while EVH trades at $5.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas EVH's P/E ratio is 570.50. In terms of profitability, SLGCW's ROE is -0.19%, compared to EVH's ROE of -0.78%. Regarding short-term risk, SLGCW is more volatile compared to EVH. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check EVH's competition here
SLGCW vs MPLN-WT Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, SLGCW is priced at $0.09, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, SLGCW is less volatile compared to MPLN-WT. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check MPLN-WT's competition here
SLGCW vs ACCD Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, SLGCW is priced at $0.09, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas ACCD's P/E ratio is -3.08. In terms of profitability, SLGCW's ROE is -0.19%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, SLGCW is more volatile compared to ACCD. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check ACCD's competition here
SLGCW vs CTEV Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, CTEV has a market cap of 552.3M. Regarding current trading prices, SLGCW is priced at $0.09, while CTEV trades at $32.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas CTEV's P/E ratio is -2.48. In terms of profitability, SLGCW's ROE is -0.19%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, SLGCW is more volatile compared to CTEV. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check CTEV's competition here
SLGCW vs SHCR Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, SLGCW is priced at $0.09, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SHCR's P/E ratio is -3.76. In terms of profitability, SLGCW's ROE is -0.19%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, SLGCW is more volatile compared to SHCR. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SHCR's competition here
SLGCW vs NRC Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, NRC has a market cap of 504.8M. Regarding current trading prices, SLGCW is priced at $0.09, while NRC trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas NRC's P/E ratio is 25.45. In terms of profitability, SLGCW's ROE is -0.19%, compared to NRC's ROE of +0.57%. Regarding short-term risk, SLGCW is more volatile compared to NRC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check NRC's competition here
SLGCW vs SLGC Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, SLGCW is priced at $0.09, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SLGC's P/E ratio is -3.04. In terms of profitability, SLGCW's ROE is -0.19%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, SLGCW is more volatile compared to SLGC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SLGC's competition here
SLGCW vs TBRG Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, SLGCW is priced at $0.09, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas TBRG's P/E ratio is 9.37. In terms of profitability, SLGCW's ROE is -0.19%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, SLGCW is more volatile compared to TBRG. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check TBRG's competition here
SLGCW vs MPLN Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, SLGCW is priced at $0.09, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas MPLN's P/E ratio is -0.23. In terms of profitability, SLGCW's ROE is -0.19%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, SLGCW is more volatile compared to MPLN. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check MPLN's competition here
SLGCW vs SLP Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SLP has a market cap of 371.6M. Regarding current trading prices, SLGCW is priced at $0.09, while SLP trades at $18.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SLP's P/E ratio is 17.85. In terms of profitability, SLGCW's ROE is -0.19%, compared to SLP's ROE of -0.49%. Regarding short-term risk, SLGCW is more volatile compared to SLP. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SLP's competition here
SLGCW vs SOPH Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SOPH has a market cap of 367.8M. Regarding current trading prices, SLGCW is priced at $0.09, while SOPH trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SOPH's P/E ratio is -10.29. In terms of profitability, SLGCW's ROE is -0.19%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, SLGCW is more volatile compared to SOPH. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SOPH's competition here
SLGCW vs TRHC Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, SLGCW is priced at $0.09, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas TRHC's P/E ratio is -4.27. In terms of profitability, SLGCW's ROE is -0.19%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, SLGCW is more volatile compared to TRHC. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check TRHC's competition here
SLGCW vs SMFR Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, SLGCW is priced at $0.09, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SMFR's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, SLGCW is more volatile compared to SMFR. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SMFR's competition here
SLGCW vs SPOK Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SPOK has a market cap of 219.1M. Regarding current trading prices, SLGCW is priced at $0.09, while SPOK trades at $10.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SPOK's P/E ratio is 17.48. In terms of profitability, SLGCW's ROE is -0.19%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, SLGCW is more volatile compared to SPOK. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SPOK's competition here
SLGCW vs SY Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SY has a market cap of 202.1M. Regarding current trading prices, SLGCW is priced at $0.09, while SY trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SY's P/E ratio is -4.67. In terms of profitability, SLGCW's ROE is -0.19%, compared to SY's ROE of -0.16%. Regarding short-term risk, SLGCW is more volatile compared to SY. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SY's competition here
SLGCW vs AMWL Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, AMWL has a market cap of 154.8M. Regarding current trading prices, SLGCW is priced at $0.09, while AMWL trades at $9.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas AMWL's P/E ratio is -1.79. In terms of profitability, SLGCW's ROE is -0.19%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, SLGCW is more volatile compared to AMWL. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check AMWL's competition here
SLGCW vs HCAT Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, HCAT has a market cap of 153.7M. Regarding current trading prices, SLGCW is priced at $0.09, while HCAT trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas HCAT's P/E ratio is 10.40. In terms of profitability, SLGCW's ROE is -0.19%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, SLGCW is more volatile compared to HCAT. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check HCAT's competition here
SLGCW vs CPSI Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, SLGCW is priced at $0.09, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas CPSI's P/E ratio is -183.80. In terms of profitability, SLGCW's ROE is -0.19%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, SLGCW is more volatile compared to CPSI. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check CPSI's competition here
SLGCW vs OPRX Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, OPRX has a market cap of 116.2M. Regarding current trading prices, SLGCW is priced at $0.09, while OPRX trades at $6.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas OPRX's P/E ratio is 5.68. In terms of profitability, SLGCW's ROE is -0.19%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, SLGCW is more volatile compared to OPRX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check OPRX's competition here
SLGCW vs AUGX Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, SLGCW is priced at $0.09, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas AUGX's P/E ratio is -4.99. In terms of profitability, SLGCW's ROE is -0.19%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, SLGCW is more volatile compared to AUGX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check AUGX's competition here
SLGCW vs CCLD Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, CCLD has a market cap of 94.3M. Regarding current trading prices, SLGCW is priced at $0.09, while CCLD trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas CCLD's P/E ratio is 6.73. In terms of profitability, SLGCW's ROE is -0.19%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, SLGCW is more volatile compared to CCLD. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check CCLD's competition here
SLGCW vs DH Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, DH has a market cap of 82.3M. Regarding current trading prices, SLGCW is priced at $0.09, while DH trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas DH's P/E ratio is 3.00. In terms of profitability, SLGCW's ROE is -0.19%, compared to DH's ROE of -0.67%. Regarding short-term risk, SLGCW is more volatile compared to DH. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check DH's competition here
SLGCW vs FORA Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, SLGCW is priced at $0.09, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas FORA's P/E ratio is -24.11. In terms of profitability, SLGCW's ROE is -0.19%, compared to FORA's ROE of -0.17%. Regarding short-term risk, SLGCW is more volatile compared to FORA. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check FORA's competition here
SLGCW vs CCLDP Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, SLGCW is priced at $0.09, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas CCLDP's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, SLGCW is more volatile compared to CCLDP. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check CCLDP's competition here
SLGCW vs ONMD Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, ONMD has a market cap of 36.4M. Regarding current trading prices, SLGCW is priced at $0.09, while ONMD trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas ONMD's P/E ratio is -4.46. In terms of profitability, SLGCW's ROE is -0.19%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, SLGCW is more volatile compared to ONMD. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check ONMD's competition here
SLGCW vs SNCE Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, SLGCW is priced at $0.09, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SNCE's P/E ratio is -0.27. In terms of profitability, SLGCW's ROE is -0.19%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, SLGCW is more volatile compared to SNCE. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SNCE's competition here
SLGCW vs AKLI Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, SLGCW is priced at $0.09, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas AKLI's P/E ratio is -0.71. In terms of profitability, SLGCW's ROE is -0.19%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, SLGCW is more volatile compared to AKLI. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check AKLI's competition here
SLGCW vs SHLT Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, SLGCW is priced at $0.09, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SHLT's P/E ratio is -3.87. In terms of profitability, SLGCW's ROE is -0.19%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, SLGCW is more volatile compared to SHLT. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SHLT's competition here
SLGCW vs SHCRW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, SLGCW is priced at $0.09, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, SLGCW's ROE is -0.19%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, SLGCW is more volatile compared to SHCRW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SHCRW's competition here
SLGCW vs ONMDW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, ONMDW has a market cap of 30.4M. Regarding current trading prices, SLGCW is priced at $0.09, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas ONMDW's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, SLGCW is less volatile compared to ONMDW. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check ONMDW's competition here
SLGCW vs EUDA Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, EUDA has a market cap of 26.7M. Regarding current trading prices, SLGCW is priced at $0.09, while EUDA trades at $13.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas EUDA's P/E ratio is -2.63. In terms of profitability, SLGCW's ROE is -0.19%, compared to EUDA's ROE of +0.13%. Regarding short-term risk, SLGCW is more volatile compared to EUDA. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check EUDA's competition here
SLGCW vs STRM Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, SLGCW is priced at $0.09, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas STRM's P/E ratio is -2.40. In terms of profitability, SLGCW's ROE is -0.19%, compared to STRM's ROE of -0.32%. Regarding short-term risk, SLGCW is more volatile compared to STRM. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check STRM's competition here
SLGCW vs RNLX Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, SLGCW is priced at $0.09, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas RNLX's P/E ratio is -0.33. In terms of profitability, SLGCW's ROE is -0.19%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, SLGCW is more volatile compared to RNLX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check RNLX's competition here
SLGCW vs LIFW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, SLGCW is priced at $0.09, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas LIFW's P/E ratio is -0.02. In terms of profitability, SLGCW's ROE is -0.19%, compared to LIFW's ROE of +3.93%. Regarding short-term risk, SLGCW is more volatile compared to LIFW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check LIFW's competition here
SLGCW vs BEATW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, BEATW has a market cap of 20.3M. Regarding current trading prices, SLGCW is priced at $0.09, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas BEATW's P/E ratio is -0.06. In terms of profitability, SLGCW's ROE is -0.19%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, SLGCW is less volatile compared to BEATW. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check BEATW's competition here
SLGCW vs BBLN Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, SLGCW is priced at $0.09, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas BBLN's P/E ratio is -0.04. In terms of profitability, SLGCW's ROE is -0.19%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, SLGCW is more volatile compared to BBLN. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check BBLN's competition here
SLGCW vs ETAO Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, SLGCW is priced at $0.09, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas ETAO's P/E ratio is -0.01. In terms of profitability, SLGCW's ROE is -0.19%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, SLGCW is less volatile compared to ETAO. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check ETAO's competition here
SLGCW vs BFRG Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, BFRG has a market cap of 8M. Regarding current trading prices, SLGCW is priced at $0.09, while BFRG trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas BFRG's P/E ratio is -1.27. In terms of profitability, SLGCW's ROE is -0.19%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, SLGCW is more volatile compared to BFRG. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check BFRG's competition here
SLGCW vs HLTH Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, SLGCW is priced at $0.09, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas HLTH's P/E ratio is -0.02. In terms of profitability, SLGCW's ROE is -0.19%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, SLGCW is more volatile compared to HLTH. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check HLTH's competition here
SLGCW vs UPH-WT Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, SLGCW is priced at $0.09, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, SLGCW is less volatile compared to UPH-WT. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check UPH-WT's competition here
SLGCW vs UPH Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, SLGCW is priced at $0.09, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas UPH's P/E ratio is -0.07. In terms of profitability, SLGCW's ROE is -0.19%, compared to UPH's ROE of -1.05%. Regarding short-term risk, SLGCW is more volatile compared to UPH. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check UPH's competition here
SLGCW vs SCNX Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, SLGCW is priced at $0.09, while SCNX trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas SCNX's P/E ratio is -0.14. In terms of profitability, SLGCW's ROE is -0.19%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, SLGCW is more volatile compared to SCNX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check SCNX's competition here
SLGCW vs MGRX Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, MGRX has a market cap of 4.8M. Regarding current trading prices, SLGCW is priced at $0.09, while MGRX trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas MGRX's P/E ratio is -0.35. In terms of profitability, SLGCW's ROE is -0.19%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, SLGCW is more volatile compared to MGRX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check MGRX's competition here
SLGCW vs PEAR Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, SLGCW is priced at $0.09, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas PEAR's P/E ratio is -0.08. In terms of profitability, SLGCW's ROE is -0.19%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, SLGCW is less volatile compared to PEAR. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check PEAR's competition here
SLGCW vs PEARW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, SLGCW is priced at $0.09, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas PEARW's P/E ratio is -0.00. In terms of profitability, SLGCW's ROE is -0.19%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, SLGCW is more volatile compared to PEARW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check PEARW's competition here
SLGCW vs OTRK Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, SLGCW is priced at $0.09, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas OTRK's P/E ratio is -0.02. In terms of profitability, SLGCW's ROE is -0.19%, compared to OTRK's ROE of -1.66%. Regarding short-term risk, SLGCW is more volatile compared to OTRK. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check OTRK's competition here
SLGCW vs HCTI Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, HCTI has a market cap of 2.2M. Regarding current trading prices, SLGCW is priced at $0.09, while HCTI trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas HCTI's P/E ratio is -0.02. In terms of profitability, SLGCW's ROE is -0.19%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, SLGCW is more volatile compared to HCTI. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check HCTI's competition here
SLGCW vs VSEE Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, VSEE has a market cap of 1.8M. Regarding current trading prices, SLGCW is priced at $0.09, while VSEE trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas VSEE's P/E ratio is -0.22. In terms of profitability, SLGCW's ROE is -0.19%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, SLGCW is more volatile compared to VSEE. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check VSEE's competition here
SLGCW vs ACON Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, ACON has a market cap of 1.6M. Regarding current trading prices, SLGCW is priced at $0.09, while ACON trades at $3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas ACON's P/E ratio is -0.29. In terms of profitability, SLGCW's ROE is -0.19%, compared to ACON's ROE of -0.54%. Regarding short-term risk, SLGCW is more volatile compared to ACON. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check ACON's competition here
SLGCW vs CMAX Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, SLGCW is priced at $0.09, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas CMAX's P/E ratio is -0.00. In terms of profitability, SLGCW's ROE is -0.19%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, SLGCW is more volatile compared to CMAX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check CMAX's competition here
SLGCW vs VSEEW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, VSEEW has a market cap of 1.5M. Regarding current trading prices, SLGCW is priced at $0.09, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, SLGCW's ROE is -0.19%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, SLGCW is more volatile compared to VSEEW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check VSEEW's competition here
SLGCW vs BFRGW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, SLGCW is priced at $0.09, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, SLGCW's ROE is -0.19%, compared to BFRGW's ROE of -2.18%. Regarding short-term risk, SLGCW is more volatile compared to BFRGW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check BFRGW's competition here
SLGCW vs LIFWZ Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, SLGCW is priced at $0.09, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to LIFWZ's ROE of +3.93%. Regarding short-term risk, SLGCW is more volatile compared to LIFWZ. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check LIFWZ's competition here
SLGCW vs EUDAW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, EUDAW has a market cap of 1M. Regarding current trading prices, SLGCW is priced at $0.09, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, SLGCW's ROE is -0.19%, compared to EUDAW's ROE of +0.13%. Regarding short-term risk, SLGCW is more volatile compared to EUDAW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check EUDAW's competition here
SLGCW vs MSPRZ Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, SLGCW is priced at $0.09, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to MSPRZ's ROE of +3.93%. Regarding short-term risk, SLGCW is less volatile compared to MSPRZ. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check MSPRZ's competition here
SLGCW vs WORX Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, WORX has a market cap of 303.5K. Regarding current trading prices, SLGCW is priced at $0.09, while WORX trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas WORX's P/E ratio is -1.17. In terms of profitability, SLGCW's ROE is -0.19%, compared to WORX's ROE of -0.65%. Regarding short-term risk, SLGCW is less volatile compared to WORX. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check WORX's competition here
SLGCW vs KERNW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, SLGCW is priced at $0.09, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas KERNW's P/E ratio is -0.00. In terms of profitability, SLGCW's ROE is -0.19%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, SLGCW is less volatile compared to KERNW. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check KERNW's competition here
SLGCW vs KERN Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, SLGCW is priced at $0.09, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas KERN's P/E ratio is -0.01. In terms of profitability, SLGCW's ROE is -0.19%, compared to KERN's ROE of -0.17%. Regarding short-term risk, SLGCW is more volatile compared to KERN. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check KERN's competition here
SLGCW vs LIFWW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, SLGCW is priced at $0.09, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas LIFWW's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to LIFWW's ROE of +3.93%. Regarding short-term risk, SLGCW is more volatile compared to LIFWW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check LIFWW's competition here
SLGCW vs ZCMD Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, ZCMD has a market cap of 37.7K. Regarding current trading prices, SLGCW is priced at $0.09, while ZCMD trades at $1.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas ZCMD's P/E ratio is -0.04. In terms of profitability, SLGCW's ROE is -0.19%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, SLGCW is more volatile compared to ZCMD. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check ZCMD's competition here
SLGCW vs CMAXW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, SLGCW is priced at $0.09, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas CMAXW's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, SLGCW is more volatile compared to CMAXW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check CMAXW's competition here
SLGCW vs ACONW Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, ACONW has a market cap of 12.3K. Regarding current trading prices, SLGCW is priced at $0.09, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas ACONW's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, SLGCW is more volatile compared to ACONW. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check ACONW's competition here
SLGCW vs NAVA Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, SLGCW is priced at $0.09, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas NAVA's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, Volatility data is not available for a full comparison. SLGCW has daily volatility of 28.69 and NAVA has daily volatility of N/A.Check NAVA's competition here
SLGCW vs AFFX Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, SLGCW is priced at $0.09, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas AFFX's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, SLGCW is more volatile compared to AFFX. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check AFFX's competition here
SLGCW vs CHNGU Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, SLGCW is priced at $0.09, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas CHNGU's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, SLGCW is more volatile compared to CHNGU. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check CHNGU's competition here
SLGCW vs IMS Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, IMS has a market cap of 0. Regarding current trading prices, SLGCW is priced at $0.09, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas IMS's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to IMS's ROE of +0.27%. Regarding short-term risk, SLGCW is more volatile compared to IMS. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check IMS's competition here
SLGCW vs CNVY Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, SLGCW is priced at $0.09, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas CNVY's P/E ratio is -71.50. In terms of profitability, SLGCW's ROE is -0.19%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, SLGCW is more volatile compared to CNVY. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check CNVY's competition here
SLGCW vs MSPRV Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, SLGCW is priced at $0.09, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas MSPRV's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to MSPRV's ROE of N/A. Regarding short-term risk, SLGCW is less volatile compared to MSPRV. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check MSPRV's competition here
SLGCW vs MTBCO Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, SLGCW is priced at $0.09, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas MTBCO's P/E ratio is N/A. In terms of profitability, SLGCW's ROE is -0.19%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, SLGCW is more volatile compared to MTBCO. This indicates potentially higher risk in terms of short-term price fluctuations for SLGCW.Check MTBCO's competition here
SLGCW vs NH Comparison July 2026
SLGCW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLGCW stands at 396.2M. In comparison, NH has a market cap of 0. Regarding current trading prices, SLGCW is priced at $0.09, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLGCW currently has a P/E ratio of -0.16, whereas NH's P/E ratio is -0.12. In terms of profitability, SLGCW's ROE is -0.19%, compared to NH's ROE of +0.35%. Regarding short-term risk, SLGCW is less volatile compared to NH. This indicates potentially lower risk in terms of short-term price fluctuations for SLGCW.Check NH's competition here